Definitive Contract 75N95024C00035
Award Date
9/27/24
Potential Completion Date
9/26/25
Potential Value
$300K
Federal Agency
National Institute on Drug Abuse
Awardee
Vala Sciences Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $299,976.31 Firm Fixed Price definitive contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Guild Associates Inc. (doing business as Guild Biosciences), a small business manufacturer. The contract is for the development of point-of-care HIV viral load and drug adherence assays under the NIH's Small Business Innovation Research (SBIR) program. This work was solicited under SBIR Topic 001 of the anticipated PHS-2024-1...
This is a $300,000.00 Firm Fixed Price Definitive Contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Base Pair Biotechnologies Inc., a small business concern, to develop aptasensors for measuring long-term adherence to tenofovir-based and long-acting HIV treatment regimens. The contract was awarded under the Small Business Innovation Research (SBIR) program, which is designed to stimulate technological...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH), to Vala Sciences Inc. The $880,128 definitive cost-plus-fixed-fee contract is for the development of cell-based bioassays using induced pluripotent stem (iPS) cell lines. The goal is to provide research and development services related to assays and imaging systems for pharmaceutical testing. Vala Sciences has...
This is a Cost Plus Fixed Fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Medavante, Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $625,055.25, is for research and development in physical science. The contract has a period of performance through September 16, 2011. This contract is a definitive contract, indicating it is a stand-alone award rather than being associated with a larger...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Valenti, Denise A, doing business as Immad, a self-certified small disadvantaged business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for $225,000.00 to develop digital markers for measuring marijuana intoxication through the dysfunctional response of retinal ganglion cells. The original solicitation was...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health, to Med Associates, Inc., a for-profit, woman-owned small business manufacturer and supplier of specialized scientific laboratory equipment and software. The contract award, valued at $18,898.50, is for the delivery of products that support research into substance use disorders, neurological processes, addiction mechanisms, and behavioral...
<p>This federal contract award was issued by the National Institute on Drug Abuse (NINDS), a civilian agency, to Salient Science & Technology LLC, a small business, for $80,069.86 in business development consulting services related to the pharmaceutical industry. The contract was awarded on February 27, 2017 with an ultimate completion date of April 14, 2022. It is a firm fixed-price purchase order. The contract was set aside for small businesses.</p>
This is a $1,499,871.00 Firm Fixed Price contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Scitech Strategies Inc., a for-profit, Subchapter S Corporation small business. The contract is for the creation of an accurate model of the topical structure of PubMed and associated indicators, with a period of performance from September 30, 2018 to September 29, 2020. This contract is a Small Business Innovation Research (SBIR) Program Phase II action.
This firm fixed-price purchase order contract in the amount of $85,500.00 was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Inscopix, Inc., a for-profit scientific instrumentation company. The contract is for the provision of the NVISTA HD 2.0 IN VIVO RODENT BRAIN IMAGING SYSTEM, which enables advanced neuroscience research through specialized imaging and optogenetics technologies. This equipment supports cutting-edge...